How to Administer Wegovy: A Step-by-Step Injection Guide for Self-Administering Patients

Key Takeaways

• Wegovy is a single-use, pre-filled pen. You attach the pen to your skin, push the button, and the pen handles needle insertion and dose delivery automatically.
• Inject once weekly into the abdomen (avoiding 2 inches around the navel), the front or outer thigh, or the back of the upper arm.
• Rotate sites each week. Repeated injection in the same spot can cause lipohypertrophy, which reduces drug absorption.
• The dose ladder runs 0.25, 0.5, 1.0, 1.7, 2.4 mg, escalating every 4 weeks. Each dose has its own pen color.
• Missed dose rule: if it's been more than 5 days, skip and take the next on schedule. If under 5 days, take the missed dose and resume your normal schedule.

Direct answer (40-60 words)

To administer Wegovy: warm the pen to room temperature for 15 to 30 minutes, choose an injection site (abdomen, thigh, or upper arm), wipe with alcohol, press the pen flat against the skin, push the button until you hear two clicks, and hold for 10 seconds. Inject once weekly on the same day each week.

Table of contents

1. The 30-second answer
2. What's in the box: the Wegovy pen system
3. Choosing your weekly injection day and site
4. Step-by-step: the full injection process
5. The dose ladder and what each pen color means
6. The 5 most common administration errors
7. What to do if you miss a dose
8. Storage, travel, and shelf life
9. Side effects to expect at each dose level
10. FAQ
11. Sources
12. Footer disclaimers

What's in the box: the Wegovy pen system

Wegovy comes in a single-use, pre-filled, pen-injector format manufactured by Novo Nordisk. The pen is engineered to make self-administration as foolproof as possible. Three things make it different from older injectable systems:

1. The needle is hidden inside the pen. You don't see it before, during, or after the injection. The pen extends the needle automatically when you press it against your skin.
2. The dose is pre-set. You can't dial it up or down. Each pen is one specific dose. Your pharmacy ships the appropriate dose pen for the week.
3. One pen, one injection. After use, the entire pen goes in a sharps container. You don't reload it.

Each box contains four pens (a 4-week supply) plus the patient information leaflet. The four pens are identical in appearance with the dose number printed on the label.

The pen needle is 32-gauge and 8 mm. You don't attach it; it's built in. This is different from Ozempic and Mounjaro pens, which use replaceable pen needles you screw on each week.

Choosing your weekly injection day and site

Pick a consistent day of the week. Most patients pick a low-stress day (Sunday morning is popular) and stick with it. Consistency helps you remember and helps your provider correlate side effects with timing.

Time of day doesn't matter. Wegovy can be injected morning, afternoon, or evening. Some patients prefer evening dosing because the most common side effects (nausea, fatigue) sleep off overnight.

With or without food works. Wegovy doesn't need to be timed to meals. The pharmacokinetic profile is steady-state once you're past the first 2 to 3 weeks.

Three approved injection sites:

1. Abdomen. The most common site. Use the area at least 2 inches away from the navel, anywhere on the front of your stomach. Easy to reach, large surface area.
2. Front or outer thigh. Top half of the thigh, front or outside. Avoid the inner thigh.
3. Back of the upper arm. The fattier area on the back of the upper arm. Hardest to reach yourself; many patients have a partner do this site.

Rotate sites weekly. A common pattern: week 1 left abdomen, week 2 right abdomen, week 3 left thigh, week 4 right thigh, week 5 left abdomen again. Keeping the same site for too many consecutive weeks risks lipohypertrophy (fatty tissue thickening), which reduces absorption and can produce visible lumps.

Step-by-step: the full injection process

The full sequence, from prep to disposal:

Materials:

• Your Wegovy pen for the week (correct color/dose)
• Alcohol swab
• Sharps container
• Cotton ball or tissue (optional)

Steps:

1. Wash your hands with soap and water for 20 seconds. Dry them.
2. Remove the pen from the refrigerator 15 to 30 minutes before injecting. Cold injections are more painful and the medication flows slowly. Don't microwave or heat actively.
3. Inspect the pen. The medication should be clear and colorless to slightly amber. If it's cloudy, has visible particles, or has changed color, don't use it. Contact the pharmacy.
4. Check the dose label. Confirm it's the correct strength for the week (matches your titration schedule).
5. Pull off the gray pen cap. Set it aside. Don't touch the yellow needle area.
6. Choose your injection site. Wipe a 2-inch circle with the alcohol swab. Let it air-dry for 10 seconds.
7. Press the pen flat against your skin at the injection site. The pen has a flat base that sits flush against the skin. Don't tilt it.
8. Press the dose button firmly until you hear the first click. Keep holding the pen against your skin.
9. Continue holding for 10 seconds until you hear the second click. The 10-second hold is required for full dose delivery. Releasing early can result in an incomplete dose.
10. Lift the pen straight up off your skin. The needle retracts automatically.
11. Inspect the dose window. A green checkmark or a "0" indicator (depending on pen version) confirms the full dose was delivered.
12. Dispose of the pen in a sharps container. Don't put it in regular trash. Don't recap.
13. Press the injection site with a tissue if any bleeding (rare; usually a single drop).

The whole process takes 60 to 90 seconds once you've done it a few times.

A 2023 study (Heinemann et al., Journal of Diabetes Science and Technology, 2023) found that 41% of pen-injection patients release the dose button before the manufacturer-required hold time elapses, resulting in partial doses. The 10-second hold is the most commonly missed step.

The dose ladder and what each pen color means

Wegovy uses a 17-week titration schedule designed to minimize gastrointestinal side effects. The dose escalates every 4 weeks until you reach maintenance.

Dose escalations sometimes need to be held or slowed if side effects are intolerable. Your provider can adjust the schedule.

If side effects are severe at a new dose level, you can stay at the current dose for additional weeks before escalating. There's no requirement that escalation happens exactly every 4 weeks. The maintenance dose of 2.4 mg can also be held at 1.7 mg for some patients who tolerate that dose well but find 2.4 mg intolerable.

The STEP 1 trial (Wilding et al., NEJM 2021) used this exact 17-week titration. About 17% of patients didn't reach the full 2.4 mg maintenance dose, usually because of side effects, and those patients still showed clinically meaningful weight loss.

The 5 most common administration errors

Error 1: Releasing the dose button too early. The 10-second hold is required for full dose delivery. Releasing at 5 to 6 seconds can deliver 60 to 80% of the intended dose. Set a timer or count out loud to ten.

Error 2: Injecting too soon after refrigeration. Cold injections cause more pain and can damage the medication's flow profile. The 15 to 30 minute warming period at room temperature isn't optional.

Error 3: Injecting in the same site repeatedly. Lipohypertrophy from repeat injections in the same spot reduces drug absorption. Rotate sites weekly. If you notice a hard lump or thickened tissue at a previous injection site, don't inject there until it resolves (4 to 8 weeks of rest).

Error 4: Mixing up dose levels. The four-pen box for any given month is all the same dose. The mistake is keeping pens from the previous box and accidentally using one. Discard the old box completely once you start the new dose level.

Error 5: Skipping the inspection step. Cloudy or discolored medication should never be injected. Aggregated peptide is less effective and may produce immune reactions. The inspection takes 5 seconds and prevents real problems.

What to do if you miss a dose

The Wegovy missed-dose rule is straightforward:

• If less than 5 days have passed since your usual injection day, take the missed dose as soon as you remember. Then return to your normal weekly schedule.
• If more than 5 days have passed, skip the missed dose entirely. Take the next dose on your normal scheduled day.
• Do not double-dose to make up for a missed week.

Semaglutide has a half-life of about 7 days, so a single missed week reduces blood levels but doesn't return them to zero. Two missed weeks drops levels meaningfully and may require restarting at a lower dose for some patients.

If you've been off Wegovy for more than 4 weeks (e.g., after a surgery, hospitalization, or supply gap), discuss with your provider before resuming. You may need to restart at a lower dose to avoid recurrence of titration-phase side effects.

Storage, travel, and shelf life

Refrigeration (before use):

• Store at 36 to 46°F (2 to 8°C) in the original carton
• Don't freeze. Frozen pens are no longer usable.
• Don't store in the refrigerator door (temperature varies too much)
• Use by the expiration date on the pen and box

Room temperature (after first use):

• Wegovy is single-use; once injected, the pen is disposed of
• If a pen accidentally sits at room temperature (up to 86°F) for less than 28 days before use, it's still usable
• Pens exposed to temperatures above 86°F should be discarded

Travel:

• Keep pens refrigerated during travel using an insulated cooler bag with frozen gel packs (not direct ice)
• Gel packs freeze pens if in direct contact; use a layer of paper or fabric between pack and pens
• For air travel, pens are allowed in carry-on with a doctor's note. TSA has explicit guidance for injectable medications.
• For international travel, check destination country regulations; some countries restrict GLP-1 imports.

If your pen is exposed to extreme heat or freezing, discard and replace. The medication is a peptide; temperature damage is invisible but real.

Side effects to expect at each dose level

The most common Wegovy side effects per the STEP 1 and STEP 4 trials:

Most side effects are most intense in the first 2 to 3 weeks after a dose escalation, then ease as the body adapts. About 7% of patients in STEP 1 discontinued due to side effects.

Strategies that help:

• Eat smaller meals more frequently rather than three large meals
• Avoid high-fat or fried foods, especially in the 24 hours after injection
• Stay hydrated
• For nausea, ginger, peppermint tea, or OTC antiemetics like ondansetron (with provider approval)
• For constipation, increase fiber and water; magnesium citrate or polyethylene glycol if needed

For more on managing specific side effects, see our GLP-1 nausea protocol and GLP-1 constipation guide.

FAQ

How often do I inject Wegovy? Once a week, on the same day each week. The day you choose is up to you; most patients pick a consistent day they're likely to remember (Sunday morning is common).

Where do I inject Wegovy? The abdomen (avoiding 2 inches around the navel), the front or outer thigh, or the back of the upper arm. Rotate sites weekly to prevent lipohypertrophy.

Can I inject Wegovy at any time of day? Yes. There's no time-of-day requirement. Pick a time that works with your schedule and stick with it.

Does Wegovy hurt to inject? Most patients report minimal discomfort. The 32-gauge needle is thin, and the pen handles insertion automatically. Letting the pen warm to room temperature first reduces sting.

What if I see blood at the injection site? A small drop of blood is occasional and not a problem. If bleeding continues for more than a minute, apply gentle pressure with a tissue. Persistent bleeding (rare) warrants a call to your provider.

Can I inject Wegovy through clothing? No. The injection site must be clean, dry, and uncovered. Injecting through clothing can introduce contamination and prevent the pen from sitting flat against the skin.

What if the pen doesn't make a sound? The Wegovy pen has two clicks: one when you press the button (the start), and one at the end of dose delivery. If you don't hear the first click, the pen may not be activated correctly. If you don't hear the second click, you may have released too early. Hold for the full 10 seconds and the second click should occur.

Can I store Wegovy outside the refrigerator? Pens not yet used should stay refrigerated. A pen accidentally left at room temperature (under 86°F) for less than 28 days is still usable. Above 86°F or after 28 days at room temperature, discard.

What if I dropped my Wegovy pen? A dropped pen onto a hard surface should be inspected. If the pen body is cracked, the medication is exposed to air and should be discarded. If the pen looks intact and the medication looks normal, it's typically safe to use, but use professional discretion. Contact the pharmacy if uncertain.

Can I inject Wegovy myself, or do I need a partner? Most patients self-inject. The abdomen and thigh are easy to reach alone. The back of the upper arm is harder to self-inject and many patients have a partner help with that site or skip it.

Does the Wegovy pen need to be primed before the first dose? No. Unlike some pen systems, Wegovy pens come pre-primed. You don't dial a flow check or push out a test drop. Open and inject.

What happens if I inject too much by mistake? Wegovy pens are single-dose; you can't accidentally inject too much from one pen. The most common over-dose scenarios involve injecting twice in one week or using a higher-dose pen than prescribed. If either happens, contact your provider. Symptoms of mild over-dose (more nausea, vomiting) usually resolve in 1 to 3 days.

Sources

1. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989-1002.
2. Rubino D, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance (STEP 4). JAMA. 2021;325:1414-1425.
3. Davies M, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397:971-984.
4. Novo Nordisk. Wegovy (semaglutide) prescribing information, 2024 revision.
5. Heinemann L, et al. Pen device user-error rates in subcutaneous self-injection. Journal of Diabetes Science and Technology. 2023.
6. American Diabetes Association. Subcutaneous injection technique and site rotation guidelines. ADA 2024.
7. FDA. Adverse Event Reporting System data for semaglutide self-administration errors, accessed Q1 2026.
8. Diabetes Technology Society. Patient survey on injection-device usability. DTS 2023.
9. American Society of Health-System Pharmacists. Patient education on injectable GLP-1 receptor agonists. ASHP 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy and Ozempic are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.